
Cibus, Inc.
NASDAQCBUS short share utilization hits 92.23%, near the 52-week peak of 100%, signaling intensifying demand to borrow stock in this heavily shorted biotech name.
Snapshot as of 7 May 2026
No long-form analysis yet for CBUS. Pulse alerts and the live data picture are available on ORTEX.
Open CBUS on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CBUS — free to start on ORTEX.
Sign up for free →Open CBUS on ORTEX